Impairments in CB‐dependent synaptic gephyrin clustering lead to severe neurological dysfunctions such as epilepsy, anxiety, aggression, and intellectual disabilities (Chiou et al. 2019; Kalscheuer et al. 2009). The gene discussed is GPHN; the disease is epilepsy.